The elderly with coronary artery disease represent an
|
|
- Jessie Carr
- 5 years ago
- Views:
Transcription
1 Ischemic Preconditioning Is Not Cardioprotective in Senescent Human Myocardium Babett Bartling, PhD, Ivar Friedrich, MD, Rolf-E. Silber, MD, and Andreas Simm, PhD Cardiothoracic Surgery, Martin Luther University Halle-Wittenberg, Halle/Saale, Germany Background. Cellular and functional changes secondary to aging could impair myocardial tolerance to ischemia and affect the heart s response to ischemic preconditioning. Methods. We investigated the impact of cardiac aging on preconditioning in right atrial trabeculae of adult patients (< 55 years) and senescent patients (> 70 years) with coronary artery disease. Specimens were subjected to 30 minutes of simulated ischemia (hypoxic substratefree superfusion) with and without 5 minutes of ischemic pretreatment. Postischemic contractile recovery was measured and expressed as percentage of base line force values. Results. During the reoxygenation period, trabeculae of adult patients but not those of senescent patients improved after ischemic preconditioning. After 40 minutes of reoxygenation, preconditioned adult trabeculae developed 57% 5% of their preischemic force (nonpreconditioned control 44% 5%, p < 0.01), senescent Accepted for publication Jan 18, Address reprint requests to Dr Simm, Klinik fuer Herz- und Thoraxchirurgie, Martin-Luther-Universitaet Halle-Wittenberg, Ernst-Grube-Str 40, D Halle, Saale, Germany; andreas.simm@medizin.unihalle.de. trabeculae recovered to 44% 4% (control 45% 3%). Especially myocardium from adult patients with Canadian Cardiovascular Society (CCS) stage III angina pectoris treated with ACE inhibitors recovered well (70% 7%; control 50% 8%, p < 0.01), contrasting with trabeculae from patients with CCS stage II angina (44% 5%; control 40% 10%). Ischemia-inducible Hsp70 (human heat shock protein) was additionally measured after reoxygenation. Total Hsp70 mrna was elevated in preconditioned myocardium along with its contractile recovery (r 0.33, p 0.07). Because the control transcription, analyzing 18S rrna and -actin, was reduced by ischemia but recovered in preconditioned trabeculae, relative Hsp70 mrna was not altered. Conclusions. Our data indicate that ischemic preconditioning has no beneficial effect on the postischemic functional recovery of senescent human myocardium. (Ann Thorac Surg 2003;76:105 11) 2003 by The Society of Thoracic Surgeons The elderly with coronary artery disease represent an increasingly important and challenging patient population. Compared with younger patients this group experiences impaired recovery of myocardial function after cardiac surgery and after other cardiac interventions [1, 2], an observation that is undoubtedly attributable to age-related structural and functional changes. Such changes may also explain why acute myocardial infarction has a poor prognosis and high mortality among the elderly [3]. The increased sensitivity of the aging myocardium to ischemia [4] could also be a central risk factor in patients who are to undergo coronary artery bypass grafting. Pretreating myocardium with brief intervals of ischemia and reperfusion diminishes cardiac damage induced by prolonged ischemia, leading to less myocyte necrosis and better functional recovery [5, 6]. This important phenomenon is called ischemic preconditioning and can be observed in different species. Clinically, ischemic preconditioning might play a role in successive exerciseinduced ischemia (warm-up phenomenon) [7] and in mediating the protective effect of preinfarction angina pectoris [8]. In patients undergoing open heart procedures additional protection against ischemia-reperfusion injury can be induced by prior aortic cross clamping [9]. Abete and coworkers [10] showed in rats however that the effect of ischemic preconditioning is reduced in senescent myocardium. Retrospective analyses of human data also suggest a limited cardioprotective effect of preconditioning in the elderly [11, 12]. Detailed experimental evidence is lacking however, and no data are published on the potential therapeutic impact. Therefore we subjected isolated human myocardium from adult and senescent patients with coronary artery disease to ischemic pretreatment and subsequent simulated ischemia in a superfusion in vitro model. Because cardiac ischemia induces several compensatory cardioprotective responses such as strong upregulation of inducible isoforms of heat shock proteins [13], we also measured mrna levels of Hsp70, the most abundant human heat shock protein. Material and Methods Experimental Procedure Right atrial trabeculae obtained from adult patients (aged 37 to 55 years) and senescent patients (aged 70 to 82 years) undergoing coronary bypass surgery were used in this study. All patients suffered from coronary artery disease (CAD) with angina pectoris but without atrioventricular valve defects. Exclusion criteria were right atrial pressures more than 12 mm Hg, atrial arrhythmias, and 2003 by The Society of Thoracic Surgeons /03/$30.00 Published by Elsevier Inc PII S (03)
2 106 BARTLING ET AL Ann Thorac Surg ISCHEMIC PRECONDITIONING IN CARDIAC AGING 2003;76: Table 1. Clinical Data of Coronary Artery Disease Patients Group Number of Patients Age (Years) CAD Heart Disease CAD, AVD CAD, AS -Blocker Therapy CCS Stage Angina Pectoris ACE Inhibitor Nitrate I II III (%) Left Ventricular Ejection Fraction Low: 60% High: 60% ND MAP (mm Hg) PCWP (mm Hg) Adult Senescent Data are means SEM. ACE angiotensin-converting enzyme; AS aortic stenosis; AVD aortic valve disease; CCS Canadian Cardiovascular Society; MAP mean aortic pressure; ND not determined; PCWP pulmonary capillary wedge pressure. diabetes mellitus. Detailed patient characteristics are summarized in Table 1. The study was approved by the local ethics committee (2001). Experiments were performed in accordance with the slightly modified protocol described by the Yellon group [6]. Immediately after removal atrial myocardium was kept in Tyrode s solution that was oxygenated with 95% O 2 /5% CO 2 to yield a ph of 7.5. Fresh Tyrode s solution was prepared on a daily basis. It contained 5 mmol/l D-glucose, 1.8 mmol/l CaCl 2, 120 mmol/l NaCl, 5.4 mmol/l KCl, 1.05 mmol/l MgCl 2, 22.6 mmol/l NaHCO 3, 0.42 mmol/l Na 2 HPO 4, 0.05 mmol/l Na 2 EDTA, and 0.28 mmol/l ascorbic acid. Four trabeculae from each right atrial appendage were dissected and placed horizontally in an organ bath containing continuously oxygenated Tyrode s solution at 37 C. Once suspended, specimens were electrically stimulated at 1 Hz using platinum electrodes. A Modular Stimulator II (Hugo Sachs Elektronik, March-Hugstetten, Germany) produced a fixed pulse width of 1 ms and a mean pulse amplitude of 10 V (Table 2). Tensions were registered by a force transducer connected to a Servomed amplifier (Hellige, Freiburg, Germany). During the initial equilibration period of 60 minutes trabeculae were gradually stretched until the force of contraction was maximized. Thereafter, specimens were subjected to 30 minutes of experimental ischemia (hypoxic substrate-free Tyrode s solution) in combination with rapid pacing at 3 Hz, followed by 90 minutes of reoxygenation (normoxic solution exchanged every 20 minutes and finally after 30 minutes, stimulation at 1 Hz). To create ischemic conditions, Tyrode s solution was replaced by a glucose-free solution and the gas supply was switched to 95% N 2 /5% CO 2 ; 7 mmol/l choline chloride was added to maintain constant osmolarity. Immediate desaturation to below 0.1% oxygen was verified with a Oxi 330i gas analyzer (WTW, Weilheim, Germany). In each experiment two trabeculae were ischemically preconditioned for 5 minutes followed by 10 minutes of reoxygenation, the most efficient preconditioning protocol for human atrial trabeculae [14]. The isometric force was recorded on paper and expressed in Nm (Servored 460; GMC Instruments, Nuernberg, Germany). Force of contraction was expressed as the percentage force of preischemic base line values. The exact base line functional characteristics of preconditioned and control trabeculae are listed in Table 2. Trabeculae of additional CAD patients (aged 55 to 70 years) that were superfused in the same time course but without ischemia served as nonischemic controls. RNA Preparation and Reverse Transcription Polymerase Chain Reaction (RT-PCR) For expression analyses trabeculae were immediately frozen in liquid nitrogen. Total RNA was extracted by the acid guanidinium thiocyanate-phenol-chloroform method and thereafter cleaned up with the RNeasy Mini Kit (Qiagen, Hilden, Germany). In a reverse transcription (RT) reaction, cdna was synthesized from 200 ng of total RNA with 100 U Superscript II reverse transcriptase (Invitrogen, Groningen, Netherlands) at 42 C for 60 minutes. For polymerase chain reaction (PCR), primers for hsp70 (XM004188; sense 5 CCGAGAAGGAC GAGTTT- GAG 3 ; antisense 5 GGAAATGCAAAGTCTTGAAGC 3 ), -actin (XM037235; sense 5 GAAGTGTGACGTGGA- CATCCG 3 ; antisense 5 AGCATTT GCGGTGGACGAT), and 18S rrna (M10098; sense 5 GTTGGTGGAGCGA- TTTGTCTG 3 ; antisense 5 AGGGC AGGGACTTAAT- CAACGC 3 ) were chosen. A 1/10 cdna reaction was used for PCR containing 1.5 mmol/l MgCl 2, 5 pmol of each primer, 10 mol/l of each dntp, and 1 U rtaqdna polymerase (Promega, Mannheim, Germany) in a final volume of 25 L. Polymerase chain reaction amplification Table 2. Baseline Data of Right Atrial Trabeculae Subjected to Simulated Ischemia Group Number of Patients Trabeculae Weight (g) Pulse Amplitude (V) Developed Contractile Force (mn) Control IP All Control IP All Control IP All Adult a Senescent Data are means SEM. a p 0.05 vs senescent group. IP trabeculae subjected to 5 minutes of ischemic preconditioning.
3 Ann Thorac Surg BARTLING ET AL 2003;76: ISCHEMIC PRECONDITIONING IN CARDIAC AGING was performed after initial denaturation at 95 C for 2 minutes, 20 seconds at 94 C, 20 seconds at the primerspecific annealing temperature (60 C for 18S rrna, -actin; 58 C for hsp70), and 30 seconds at 72 C. After gelelectrophoretic separation, intensity of PCR products was densitometrically evaluated (AIDA software; BioRad, Munich, Germany). Data Analysis All data are means SEM. The number of patients in each evaluation group is given in Table 1. To compare preconditioned with control myocardium of the same patient, Student s paired t test was used (SigmaStat software; Jandel, San Rafael, CA). For statistical evaluation of independent data, Student s unpaired t test was applied. Single postischemic contractile force values always refer to 40 minutes of reoxygenation representing about half of the reoxygenation period. A p value of 0.05 or less was accepted as indicating a significant difference in mean values. 107 Results This study shows that the contractile force of isolated atrial myocardium from CAD patients recovers after ischemic preconditioning and simulated ischemia. Contractile force recovery was 50% 3.1% after 40 minutes (44% 2.7% in nonpreconditioned ischemic controls, p 0.05) and 34% 2.9% after 90 minutes of reoxygenation (control 29% 2.7%, p 0.05). Effects of Age and Clinical Variables Age-dependent subgroup analysis revealed that preconditioning is primarily protective in adult CAD patients (55 years or younger). Atrial trabeculae from adults showed not only better base line contractility (Table 2) but also significantly better preservation of the postischemic function by preconditioning whereas preconditioning had no protective effect on trabeculae from patients older than 70 years (Fig 1). As depicted in Figure 2 contractile recovery of adult myocardium depended strongly on the anginal stage Canadian Cardiovascular Society (CCS). In our adult population with CCS stage III angina, mean aortic pressures were higher (91 4mm Hg compared with 77 4 mm Hg in CCS II patients, p 0.05), and left ventricular ejection fraction (LVEF) tended to be lowered (51% 5% versus 63% 3% in CCS II, p 0.08) in this group that benefited most from preconditioning. Detailed analysis of the left ventricular function above and below the mean LVEF of 60%, which has been calculated from all CAD patients of the study, did not indicate a different preconditioning effect between patients with LVEF of 60% or less and those with LVEF more than 60%. Age-related evaluation of the ejection fraction revealed that especially low LVEF but adult CAD patients showed a significant preconditioning impact. Adults with such low ejection fractions (LVEF 48% 3%) are frequently characterized by CCS stage III angina (n 5 of 9), whereas the adult high LVEF group (69% 3%) includes only 2 of 7 patients with CCS III. As shown in Fig 1. Ischemic preconditioning in isolated right atrial human myocardium from adult group (top) and senescent group (bottom) of coronary artery disease patients. Data are presented as mean SEM. *p less than 0.05, **p less than 0.01 versus individual control. Open boxes ischemic control; solid boxes 5-minute ischemic preconditioning. Figure 2 nonpreconditioned myocardium from adult patients with high LVEFs proved more resistant to ischemia than trabeculae from the group with low LVEFs but was not protected by ischemic pretreatment. Effect of Drug Treatment In a further subgroup analysis of all CAD patients we studied the impact of medical treatment with -blockers, angiotensin-converting enzyme (ACE) inhibitors, and nitrates (Table 1). In all CAD patients (63 3 years) -blockers had a weak effect on the 40-minute postischemic recovery after preconditioning (52% 3.7% versus 45% 3.2% in ischemic controls, p 0.05). CAD patients without -blockers therapy were not different in mean age (66 4 years) or other clinical variables but their tissue was not protected by preconditioning (44% 5.6% postischemic force of contraction versus control 41% 5.2%). Breakdown by age revealed however no specific effect of -blockers on the preconditioned and nonpreconditioned myocardium in adult and senescent patients. In addition to -blockers, ACE inhibitors influenced
4 108 BARTLING ET AL Ann Thorac Surg ISCHEMIC PRECONDITIONING IN CARDIAC AGING 2003;76: Fig 2. Functional recovery of preconditioned atrial trabeculae of adult group (left) and senescent group (right) coronary artery disease patients after simulated ischemia versus patients Canadian Cardiovascular Society (CCS) stage angina pectoris and left ventricular ejection fraction (EF, 60% versus 60%). Mean data SEM. **p 0.01 or less versus nonpreconditioned individual control; #p 0.05 between control data. Open bars ischemic control; hatched bars 5-minute ischemic preconditioning force recovery after 40 minutes of reoxygenation. preconditioning as well. In preconditioned samples from all CAD patients (60 3 years) who were under ACE inhibitor treatment, myocardial function at half of the reoxygenation period was found to be better (52% 3.8%; control 44% 3.7%, p 0.05) than in patients without ACE inhibitors (67 3 years). This protective impact of ACE inhibitor treatment was primarily seen in adult myocardium (Fig 3). Both adult groups with and without ACE inhibitors had comparable LVEFs and CCS stages (ACE inhibitor posistive: LVEF 57% 3%, n 6of 13 CCS III; ACE inhibitor negative: LVEF 56% 8%, n 3 of 8 CCS III), but only myocardium from ACE inhibitor treated patients responded to a significant degree to preconditioning. The best recovery was observed in adult patients with CCS stage III angina and ACE inhibitor treatment (70% 7% postischemic contractility versus control 50% 8%, p 0.01) but also in adult myocardium from low LVEF patients (LVEF 60%, n 5; Fig 3). When studying the influence of nitrates we did not find an impact on the ischemic preconditioning. Whereas adult CAD patients with nitrate therapy proved to have a higher contractile force of their preconditioned trabeculae during the reoxygenation (61% 6.8% versus control 50% 6.9%, p 0.05), patients without nitrates recovered as well (54% 7.1% versus control 42% 6.2%, p 0.05). In contrast to adults cardioprotection by preconditioning was not present in senescent myocardium with or without nitrate therapy (data not shown). mrna Expression of Inducible Hsp70 To analyze the molecular basis for our observations total RNA was extracted from atrial myocardium after the reoxygenation (n 30) and quantitatively adjusted to the same amount. The mrna expression of Hsp70 was Fig 3. Influence of angiotensin-converting enzyme inhibitor (ACE-I) therapy and left ventricular ejection fraction (EF, 60% versus 60%) on postischemic contractile force of preconditioned atrial myocardium of adult group (top left) and senescent group (top right) coronary artery disease patients. Mean data SEM. **p 0.01 or less versus nonpreconditioned individual control; (#)p 0.06 between control data. (Lower panel) ACE-I negative (neg.) (left) and ACE-I positive (pos.) (right). Open bars ischemic control; hatched bars 5-minute ischemic preconditioning force recovery after 40 minutes of reoxygenation. determined in relation to -actin as control gene and to the quantity of ribosomal RNA. As indicated by 18S rrna and -actin mrna, myocardial transcription is reduced after ischemia and reoxygenation compared with nonischemic control samples (n 7) but to a less extent in preconditioned myocardium (Fig 4). Age-related analysis revealed that the endreoxygenation level of total Hsp70 mrna is increased in preconditioned trabeculae of adults and less in senescent patients (n 15 each group). Because the total level of 18S rrna and -actin mrna was changed as well, the relative expression of Hsp-70 mrna was not altered in preconditioned samples (Fig 4). However increased level of total Hsp70 mrna but not of 18S rrna (r 0.19) or -actin mrna (r 0.22) tends to correlate with the improved myocardial function by ischemic pretreatment (r 0.33, p 0.07). Comment Reduction of infarct size, less jeopardized myocardial tissue, and better functional recovery are the hallmarks of ischemic preconditioning [5, 15]. These conclusions were drawn from animal models and cannot be directly transferred to humans because of differences between species and also for ethical reasons. There are some clinical reports however that preconditioning does occur in humans as well [7, 8, 16]. In vitro studies showed that preconditioning can protect isolated, isometrically contracting human atrial trabeculae from the adverse effects of simulated ischemia [6]. All published experimental data are derived from adult but not senescent myocardium, ignoring well-known ultrastructural and biochemical alterations that occur with age that might influence
5 Ann Thorac Surg BARTLING ET AL 2003;76: ISCHEMIC PRECONDITIONING IN CARDIAC AGING Fig 4. (Top panel) Total postreoxygenation (reoxy.) level of 18S rrna and -actin mrna, adult and senescent groups, in preconditioned atrial myocardium and nonpreconditioned controls in comparison with superfused samples that were not subjected to ischemia (nonischemic controls, n 7). Cross-hatched bars nonischemic control; open bars ischemic control; hatched bars 5-minute ischemic preconditioning. (Middle panel) Graphics demonstrate the total and 18S rrna-, -actin-normalized expression of Hsp70 mrna in adult and senescent patients (n 15 each group; left total Hsp70 mrna; right relative Hsp70 mrna). (Lower panel) Amount of Hsp70 mrna in preconditioned myocardium relates to the improved contractile force after ischemic pretreatment ( subtractive difference between data of preconditioned and nonpreconditioned samples). r and p are the results of a linear regression analysis (r coefficient of correlation; p statistical significance value.) All values are means SEM; *p less than 0.05, **p less than 0.01, and ***p less than versus control. Solid circles senescent group; open triangles adult group. (RT-PCR reverse transcription polymerase chain reaction.) 109 the heart s response to ischemic stress. Our study demonstrated that age is a main determinant for the severity of postischemic dysfunction and myocardial protection achieved with ischemic preconditioning. While preconditioning has positive effects on adult myocardium it fails to preserve the contractile function after simulated ischemia in myocardium from senescent patients with CAD. Although this study does not represent the influence of natural aging alone but in combination with CAD, these data support outcome from animal models demonstrating that aging hearts become more sensitive to ischemia despite ischemic pretreatment [10, 17]. Because such induction of tolerance to cardiac ischemia appears to play a role in both the warm-up phenomenon of CAD patients [7] and in angina pectoris [8] our results may shed some light on the loss of cardioprotection observed in the elderly under these clinical conditions [11, 18]. Furthermore, ischemic preconditioning by surgical interventions with subsequent preservation of the ventricular contractility was reduced in aged patients undergoing coronary artery bypass grafting, too [19]. The benefit of preconditioning was especially observed in adult CAD patients receiving ACE inhibitors. This finding corroborates experimental evidence suggesting the preservation of the preconditioning mechanism by concomitant blocking of the angiotensin pathway [20]. However, ACE inhibitor treatment failed to influence ischemic preconditioning in senescent myocardium. Further analyses revealed that antianginal therapy with -blockers can enhance the protective effect of myocardial preconditioning too but did not influence the ischemic tolerance in nonpreconditioned myocardium. These data contradict previous reports of Suematsu and colleagues [21] that -blockers improve the resistance against ischemia but eliminate the preconditioning effect. One possible reason might be that this study used nipradilol, a nitric oxide releasing -adrenergic blocker. Exogenous nitric oxide has been shown to trigger preconditioning through formation of reactive nitrogen species while endogenous nitric oxide seems not to be involved [22]. Therefore nitrates might have an impact on our results because a patient s myocardium would not respond to any additional stimulus. However CAD patients who received nitrates before cardiac surgery did not show an altered outcome of ischemic preconditioning in adult and senescent patients. In this regard one must also take into account that exogenous nitrate was most likely washed off during the equilibration period of all analyzed trabeculae. Our study was performed with right atrial myocardium. Left ventricular hemodynamic indicators may indirectly influence preconditioning of atrial myocardium, as recently suggested by Ghosh and associates [23] who described a decline of atrial preconditioning in patients with poor cardiac function (LVEF 30%). This contradicts results of a study by Tomai [24] who especially in patients with lower LVEF ( 50%) demonstrated a protective effect of isoflurane, an anesthetic that mimics preconditioning. The findings by Ghosh and associatges [23] are also in contrast to our results because we observed a reduced ischemic tolerance of nonpreconditioned myocardium of low LVEF adults (LVEF 48% 3%, all 60%), but no loss of preconditioning. Nevertheless the LVEF-dependent data might be strongly influenced by different anginal stages. In this context we determined a beneficial effect of myocardial preconditioning in adults with severe angina pectoris (CCS stage III). These data are contrary to early experimental observations demonstrating that frequent ischemia results in an improved ischemic tolerance but also in the removal of the preconditioning mechanism [25], indicating that this myocardium is already protected by preceding ischemic episodes. However Figure 1 and other recent evidence suggest that the duration of protection is limited and repeated daily ischemic episodes can attenuate the severity of cardiac ischemia only (review [26]). This might be well possible in myocardial samples of our adult population with severe angina pectoris because we did not find an improved ischemic tolerance in nonprecon-
6 110 BARTLING ET AL Ann Thorac Surg ISCHEMIC PRECONDITIONING IN CARDIAC AGING 2003;76: ditioned myocardium but an easier inducible preconditioning mechanism. Ischemia was shown to immediately induce Hsp70, and Hsp70 may thereby contribute to the physiologic recovery of ischemic hearts [27]. Based on this fact it has been postulated that Hsp70 and other heat stress proteins might be involved in ischemic preconditioning [28]. Therefore we analyzed the Hsp70 mrna expression after reoxygenation in preconditioned and nonpreconditioned trabeculae. The most common approach to normalize gene expressions is the comparison with a constitutively expressed control gene like -actin. Because the steadystate levels of such control genes cannot always be assumed under hypoxic and other stress conditions [29] we also used the quantification of ribosomal RNA. As rrna represents about 85% of the entire RNA, it is therefore an indicator of equal RNA loading. However even rrna can be impaired as consequence of sublethal stress but recovered by Hsp70 overexpression [30]. This stress-altered gene transcription has also been shown in our study as indicated by 18S rrna as well as -actin mrna, which are clearly decreased in ischemic controls. However the amount of 18S rrna and -actin mrna was improved by preconditioning, demonstrating the cardioprotective effect in addition to the functional recovery. The Hsp70 mrna was also increased in preconditioned myocardium of adults and less in senescent patients. Nevertheless the end-reoxygenation level of the relative Hsp70 mrna (normalized per 18S rrna, -actin mrna) is not altered in senescent patients and in adults as well, who profited from the ischemic pretreatment. Although there is a tendency toward a direct correlation between increased total Hsp70 mrna and recovered contractile force by preconditioning, unchanged relative Hsp70 mrna levels do not indicate an active upregulation in preconditioned myocardium. Therefore total Hsp70 values can also result from a secondary process and do not shed any light on the controversy about the precise role of stress proteins in the outcome of ischemic preconditioning [27, 28]. Recently it has been shown that ischemic tolerance induced by the warm-up phenomenon occurs without an elevation in heat shock proteins [31]. In summary in this in vitro study we demonstrated that in the elderly, ischemic preconditioning has no beneficial impact on postischemic contractile myocardial function. As ischemic insults are unavoidable when treating CAD by coronary angioplasty or coronary artery surgery further studies should focus on alternative strategies to protect the myocardium of elderly patients with CAD. The authors greatly appreciate the technical assistance of Thekla Wangemann and Anke Graul. Furthermore, we thank Fred H. Splittgerber, MD, for critically reading the manuscript. The work was partly done in the Zentrum fuer angewandte medizinische Grundlagenforschung, ZAMED, Halle. References 1. Reynen K, Bachmann K. Coronary arteriography in elderly patients: risk, therapeutic consequences and long-term follow-up. Coron Artery Dis 1997;8: Hirose H, Amano A, Yoshida S, Takahashi A, Nagano N, Kohmoto T. Coronary artery bypass grafting in the elderly. Chest 2000;117: Goldberg RJ, Gore JM, Gurwitz JH, et al. The impact of age on the incidence and prognosis of initial acute myocardial infarction: the Worcester Heart Attack Study. Am Heart J 1989;117: Mariani J, Ou R, Bailey M, et al. Tolerance to ischemia and hypoxia is reduced in aged human myocardium. J Thorac Cardiovasc Surg 2000;120: Cohen MV, Liu GS, Downey JM. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation 1991;84: Walker DM, Walker JM, Pugsley WB, Pattison CW, Yellon DM. Preconditioning in isolated superfused human muscle. J Mol Cell Cardiol 1995;27: Kelion AD, Webb TP, Gardner MA, Ormerod OJ, Banning AP. The warm-up effect protects against ischemic left ventricular dysfunction in patients with angina. J Am Coll Cardiol 2001;37: Kloner RA, Shook T, Przyklenk K, et al. Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation 1995;91: Lu EX, Chen SX, Yuan MD, et al. Preconditioning improves myocardial preservation in patients undergoing open heart operations. Ann Thorac Surg 1997;64: Abete P, Ferrara N, Cioppa A, et al. Preconditioning does not prevent postischemic dysfunction in aging heart. J Am Coll Cardiol 1996;27: Abete P, Ferrara N, Cacciatore F, et al. Angina-induced protection against myocardial infarction in adult and elderly patients: a loss of preconditioning mechanism in the aging heart? J Am Coll Cardiol 1997;30: Napoli C, Liguori A, Cacciatore F, Rengo F, Ambrosio G, Abete P. Warm-up phenomenon detected by electrocardiographic ambulatory monitoring in adult and older patients. J Am Geriatr Soc 1999;47: Knowlton A, Brecher P, Apstein C. Rapid expression of heat shock proteins in the rabbit after brief cardiac ischemia. J Clin Invest 1991;87: Ghosh S, Standen NB, Galinanes M. Preconditioning the human myocardium by simulated ischemia: studies on the early and delayed protection. Cardiovasc Res 2000;45: Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic preconditioning protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993;87: Tomai F, Crea F, Chiariello L, Gioffre PA. Ischemic preconditioning in humans: models, mediators, and clinical relevance. Circulation 1999;100: Tani M, Suganuma Y, Hasegawa H, et al. Changes in ischemic tolerance and effects of ischemic preconditioning in middle-aged rat hearts. Circulation 1997;95: Longobardi G, Abete P, Ferrara N, et al. Warm-up phenomenon in adult and elderly patients with coronary artery disease: further evidence of the loss of ischemic preconditioning in the aging heart. J Gerontol A Biol Sci Med Sci 2000;55:M Wu ZK, Tarkka MR, Pehkonen E, et al. Beneficial effects of ischemic preconditioning on right ventricular function after coronary artery bypass grafting. Ann Thorac Surg 2000;70: Miki T, Miura T, Tsuchida A, et al. Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation. Circulation 2000;102: Suematsu Y, Ohtsuka T, Horimoto H, et al. Long-term treatment with nipradilol, a nitric oxide-releasing betaadrenergic blocker, enhances postischemic recovery and limits infarct size. Ann Thorac Surg 2002;73: Nakano A, Liu GS, Heusch G, Downey JM, Cohen MV. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol 2000;32:
7 Ann Thorac Surg BARTLING ET AL 2003;76: ISCHEMIC PRECONDITIONING IN CARDIAC AGING 23. Ghosh S, Standen NB, Galinianes M. Failure to precondition pathological human myocardium. J Am Coll Cardiol 2001;37: Tomai F, De Paulis R, Penta de Peppo A, et al. Beneficial impact of isoflurane during coronary bypass surgery on troponin I release. G Ital Cardiol 1999;29: Cohen MV, Yang XM, Downey JM. Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning. Circ Res 1994;74: Yellon DM, Dana A. The preconditioning phenomenon. Circ Res 2000;87: Benjamin IJ, McMillan DR. Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. Circ Res 1998;83: Heads R, Latchman D, Yellon DM. Differential stress protein 111 expression during early ischemic preconditioning in the rabbit heart and its relationship to adenosine receptor function. J Mol Cell Cardiol 1995;27: Zhong H, Simons JW. Direct comparison of GAPDH, -actin, cyclophilin, and 28S rrna as internal standards for quantifying RNA levels under hypoxia. Biochem Biophys Res Comm 1999;259: Van Nieuwenhoven FA, Martin X, Heijnen VVT, Conrnelussen RN, Snoeckx LHEH. HSP70-mediated acceleration of transcriptional recovery after stress is independent of ribosomal RNA synthesis. Eur J Cell Biol 2001;80: Hamilton KL, Powers SK, Sugiura T, et al. Short-term exercise training can improve myocardial tolerance to I/R without elevation in heat shock proteins. Am J Physiol 2001;281:H Southern Thoracic Surgical Association: Fiftieth Annual Meeting The Fiftieth Annual Meeting of the Southern Thoracic Surgical Association will be held November 13 15, 2003, Bonita Springs, Florida. The Postgraduate Course will be held the morning of Thursday, November 13, 2003, and will provide in-depth coverage of thoracic surgical topics selected primarily as a means to enhance and broaden the knowledge of practicing thoracic and cardiac surgeons. Manuscripts accepted for the Resident Competition need to be submitted to the STSA headquarters office no later than September 12, The Resident Award will be based on abstract, presentation, and manuscript. Applications for membership should be completed by September 15, 2003, and forwarded to William A. Walker, MD, Membership Committee Chairman, Southern Thoracic Surgical Association, 633 N Saint Clair St, Suite 2320, Chicago, IL John H. Calhoon, MD Secretary/Treasurer Southern Thoracic Surgical Association 633 N Saint Clair St, Suite 2320 Chicago, IL (800) 685-STSA or (312) fax: (312) stsa@stsa.org; website:
Myocardial ischemic preconditioning (IP) has been extensively
The protective effects of preconditioning decline in aged patients undergoing coronary artery bypass grafting Zhong-Kai Wu, MD a Erkki Pehkonen, MD a Jari Laurikka, MD a Liisa Kaukinen, MD b Eva L. Honkonen,
More informationJournal of the American College of Cardiology Vol. 38, No. 4, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 38, No. 4, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01477-2 Diabetes
More informationIschemic conditioning of human heart muscle depends on opioid-receptor system
FOLIA MEDICA CRACOVIENSIA Vol. LVII, 2, 2017: 31 39 PL ISSN 0015-5616 Ischemic conditioning of human heart muscle depends on opioid-receptor system Marcin Kunecki 1,2, Tomasz Oleksy 1, Jolanta Biernat
More informationPreconditioning is defined as the cardioprotective effects
Preconditioning Prevents Myocardial Stunning After Cardiac Transplantation Roderick W. Landymore, MD, Alexander J. Bayes, MD, J. Thomas Murphy, MD, and John H. Fris, RT King Fahad National Guard Hospital,
More informationLoss of Preconditioning by Attenuated Activation of Myocardial ATP-Sensitive Potassium Channels in Elderly Patients Undergoing Coronary Angioplasty
Loss of Preconditioning by Attenuated Activation of Myocardial ATP-Sensitive Potassium Channels in Elderly Patients Undergoing Coronary Angioplasty Tsung-Ming Lee, MD; Sheng-Fang Su, PhD; Tsai-Fwu Chou,
More informationGinkgo biloba extract postconditioning reduces myocardial ischemia reperfusion injury
Ginkgo biloba extract postconditioning reduces myocardial ischemia reperfusion injury K. Ran 1, D.-L. Yang 1, Y.-T. Chang 1, K.-M. Duan 2, Y.-W. Ou 2, H.-P. Wang 3 and Z.-J. Li 1 1 Department of Anesthesiology,
More informationJournal of the American College of Cardiology Vol. 37, No. 3, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 37, No. 3, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01182-7 CLINICAL
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST Disclosures: Research grants & clinical trials (Gilead), honoraria & clinical trials (Berlin-Chemie/Menarini) Ranolazine in Heart Failure with Preserved Ejection Fraction
More informationCardiovascular Disorders Lecture 3 Coronar Artery Diseases
Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in
More informationMyocardial Infarction
Myocardial Infarction MI = heart attack Defined as necrosis of heart muscle resulting from ischemia. A very significant cause of death worldwide. of these deaths, 33% -50% die before they can reach the
More informationHemodynamic improvement upon levosimendan treatment in low cardiac output patients following coronary artery bypass graft
Hemodynamic improvement upon levosimendan treatment in low cardiac output patients following coronary artery bypass graft M. Buerke, K. Krohe, M. Russ, C. Schneider, H. Lemm, R. Prondzinsky, I. Friedrich,
More informationCardioprotezione ed invecchiamento
55 Congresso SIGG Invecchiamento e longevità: più geni o più ambiente? Firenze, 30/11/2010-04/12/2010 Palazzo dei Congressi SESSIONE DI BIOGERONTOLOGIA Cardioprotezione ed invecchiamento P. Abete, MD,
More informationIschemic preconditioning refers to the ability of short
Current Perspective Ischemic Preconditioning in Humans Models, Mediators, and Clinical Relevance Fabrizio Tomai, MD; Filippo Crea, MD; Luigi Chiariello, MD; Pier A. Gioffrè, MD Abstract Ischemic preconditioning,
More information12 Lead EKG Chapter 4 Worksheet
Match the following using the word bank. 1. A form of arteriosclerosis in which the thickening and hardening of the vessels walls are caused by an accumulation of fatty deposits in the innermost lining
More informationJournal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 37, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01133-5 Coronary
More information1) Severe, crushing substernal chest pain 2) radiate to the neck, jaw, epigastrium, or left arm. 3- rapid and weak pulse 4- nausea (posterior MI).
1) Severe, crushing substernal chest pain 2) radiate to the neck, jaw, epigastrium, or left arm. 3- rapid and weak pulse 4- nausea (posterior MI). 5- cardiogenic shock (massive MIs >40% of the left ventricle)
More informationTitle: Bradykinin and adenosine receptors mediate desflurane induced postconditioning in human myocardium: role of reactive oxygen species
Author's response to reviews Title: Bradykinin and adenosine receptors mediate desflurane induced postconditioning in human myocardium: role of reactive oxygen species Authors: Sandrine Lemoine (sand.lemoine2@wanadoo.fr)
More informationZachary I. Hodes, M.D., Ph.D., F.A.C.C.
Zachary I. Hodes, M.D., Ph.D., F.A.C.C. Disclamer: I personally have no financial relationship with any company mentioned today. The Care Group, LLC does have a contract with Cardium to participate in
More informationIschemic heart disease
Ischemic heart disease Introduction In > 90% of cases: the cause is: reduced coronary blood flow secondary to: obstructive atherosclerotic vascular disease so most of the time it is called: coronary artery
More informationBUSINESS. Articles? Grades Midterm Review session
BUSINESS Articles? Grades Midterm Review session REVIEW Cardiac cells Myogenic cells Properties of contractile cells CONDUCTION SYSTEM OF THE HEART Conduction pathway SA node (pacemaker) atrial depolarization
More informationEmergency surgery in acute coronary syndrome
Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
More informationFAILURE IN PATIENTS WITH MYOCARDIAL INFARCTION
Br. J. clin. Pharmac. (1982), 14, 187S-19lS BENEFICIAL EFFECTS OF CAPTOPRIL IN LEFT VENTRICULAR FAILURE IN PATIENTS WITH MYOCARDIAL INFARCTION J.P. BOUNHOURE, J.G. KAYANAKIS, J.M. FAUVEL & J. PUEL Departments
More informationP F = R. Disorder of the Breast. Approach to the Patient with Chest Pain. Typical Characteristics of Angina Pectoris. Myocardial Ischemia
Disorder of the Breast Approach to the Patient with Chest Pain Anthony J. Minisi, MD Department of Internal Medicine, Division of Cardiology Virginia Commonwealth University School of Medicine William
More informationIschemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Phy
Ischemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Physician, Professor of Medicine Department of Cardiology,
More informationcardiac pre and post conditioning
cardiac pre and post conditioning i Stefan De Hert Department of Anesthesiology University Hospital Ghent University of Ghent 2010 Universitair Ziekenhuis Gent Belgium = limited exposition to a small potential
More informationHeart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United
Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United States, totaling about 750,000 individuals annually
More informationAtrial fibrillation (AF) is the most frequently encountered postoperative. Fibrillation in patients subjected to coronary artery bypass grafting CSP
Wu et al Cardiopulmonary Support and Physiology Fibrillation in patients subjected to coronary artery bypass grafting Zhong-Kai Wu, MD, PhD a Tiina Iivainen, MD, PhD b Erkki Pehkonen, MD, PhD a Jari Laurikka,
More informationCardiovascular System Notes: Heart Disease & Disorders
Cardiovascular System Notes: Heart Disease & Disorders Interesting Heart Facts The Electrocardiograph (ECG) was invented in 1902 by Willem Einthoven Dutch Physiologist. This test is still used to evaluate
More informationIschemic Mitral Valve Disease: Repair, Replace or Ignore?
Ischemic Mitral Valve Disease: Repair, Replace or Ignore? Fabio B. Jatene Full Professor of Cardiovascular Surgery, Medical School, University of São Paulo, Brazil DISCLOSURE I have no financial relationship
More informationCLINICAL APPLICATION OF ISCHEMIC PRECONDITIONING IN THE ELDERLY
Dose-Response: An International Journal Volume 8 Issue 1 Article 9 3-2010 CLINICAL APPLICATION OF ISCHEMIC PRECONDITIONING IN THE ELDERLY Pasquale Abete Università degli Studi di Napoli Federico II, Naples,
More informationIschemic heart disease carries an increased risk of malignant
Ischemic Preconditioning Suppresses Ventricular Tachyarrhythmias After Myocardial Revascularization Zhong-Kai Wu, MD; Tiina Iivainen, MD; Erkki Pehkonen, MD; Jari Laurikka, MD; Matti R. Tarkka, MD Background
More informationMEDICAL POLICY SUBJECT: TRANSMYOCARDIAL REVASCULARIZATION
MEDICAL POLICY SUBJECT: TRANSMYOCARDIAL 7/21/05, 05/18/06, 03/15/07, 02/21/08,, PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply.
More informationEffects of myocardial infarction on catheter defibrillation threshold
Purdue University Purdue e-pubs Weldon School of Biomedical Engineering Faculty Publications Weldon School of Biomedical Engineering 1983 Effects of myocardial infarction on catheter defibrillation threshold
More informationEquivalent Cardioprotection Induced by Ischemic and Hypoxic Preconditioning
Original Cardiovascular 229 Equivalent Cardioprotection Induced by Ischemic and Hypoxic Preconditioning Xujin Xiang 1 Haixia Lin 2 Jin Liu 1 Zeyan Duan 1 1 Department of Anesthesiology, West China Hospital,
More informationEHRA/EUROPACE 2011 Madrid, Spain June
EHRA/EUROPACE 2011 Madrid, Spain June 26.-29.2011 Implementing modern management in atrial fibrillation patients Proceedings from the 3rd AFNet/EHRA consensus conference EHRA Special Session Different
More informationRevascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing
Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing Evidence and Uncertainties Robert O. Bonow, MD, MS, MACC Northwestern University Feinberg School of Medicine
More informationCLINICAL INVESTIGATION OF ANTI-ANGINAL MEDICINAL PRODUCTS IN STABLE ANGINA PECTORIS
CLINICAL INVESTIGATION OF ANTI-ANGINAL MEDICINAL PRODUCTS IN STABLE ANGINA PECTORIS Guideline Title Clinical Investigation of Anti-Anginal Medicinal Products in Stable Angina Pectoris Legislative basis
More informationCommon Codes for ICD-10
Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Clinical perspective It was recently discovered that small RNAs, called micrornas, circulate freely and stably in human plasma. This finding has sparked interest in the potential
More informationIn Vivo Animal Models of Heart Disease. Why Animal Models of Disease? Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison
In Vivo Animal Models of Heart Disease Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison Why Animal Models of Disease? Heart Failure (HF) Leading cause of morbidity and mortality
More informationPotassium Efflux from Myocardial Cells Induced by Defibrillator Shock
Purdue University Purdue e-pubs Weldon School of Biomedical Engineering Faculty Publications Weldon School of Biomedical Engineering 1986 Potassium Efflux from Myocardial Cells Induced by Defibrillator
More informationImplantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure
Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure Wojciech Zareba Postinfarction patients with left ventricular dysfunction are at increased risk
More informationJournal of the American College of Cardiology Vol. 34, No. 7, by the American College of Cardiology ISSN /99/$20.
Journal of the American College of Cardiology Vol. 34, No. 7, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00440-4 Pravastatin
More informationGENE Forward primer Reverse primer FABP4 CCTTTGTGGGGACCTGGAAA TGACCGGATGACGACCAAGT CD68 AATGTGTCCTTCCCACAAGC GGCAGCAAGAGAGATTGGTC
Published in "" which should be cited to refer to this work. mrna extraction and RT-PCR Total RNA from 5 15 mg of crushed white adipose tissue was isolated using the technique described by Chomczynski
More informationJ. Schwitter, MD, FESC Section of Cardiology
J. Schwitter, MD, FESC Section of Cardiology CMR Center of the CHUV University Hospital Lausanne - CHUV Switzerland Centre de RM Cardiaque J. Schwitter, MD, FESC Section of Cardiology CMR Center of the
More informationDisclosures. Speaker s bureau: Research grant: Advisory Board: Servier International, Bayer, Merck Serono, Novartis, Boehringer Ingelheim, Lupin
Disclosures Speaker s bureau: Research grant: Advisory Board: Servier International, Bayer, Merck Serono, Novartis, Boehringer Ingelheim, Lupin Servier International, Boehringer Ingelheim Servier International,
More informationCardiogenic Shock. Carlos Cafri,, MD
Cardiogenic Shock Carlos Cafri,, MD SHOCK= Inadequate Tissue Mechanisms: Perfusion Inadequate oxygen delivery Release of inflammatory mediators Further microvascular changes, compromised blood flow and
More informationDiagnosis and Management of Acute Myocardial Infarction
Diagnosis and Management of Acute Myocardial Infarction Acute Myocardial Infarction (AMI) occurs as a result of prolonged myocardial ischemia Atherosclerosis leads to endothelial rupture or erosion that
More informationBasic and Clinical Aspects of Ischemic Preconditioning
Home SVCC Area: English - Español - Português Basic and Clinical Aspects of Ischemic Preconditioning Karin Przyklenk, PhD Heart Institute, Good Samaritan Hospital and University of Southern California,
More informationActa Physiologica Sinica
, 1999 4, 51 (2), 187 192 187 Acta Physiologica Sinica 3 1998204222 1998206203 3 (No139500052) 3 3, 221002 3 3 3 3 3 (, 200031) ( Ito), 28 d (H28, 6 h/ d), Ito (16118 4161 6132 1135 pa/ pf, P < 0105),
More informationRevascularization In HFrEF: Are We Close To The Truth. Ali Almasood
Revascularization In HFrEF: Are We Close To The Truth Ali Almasood HF epidemic 1-2% of the population have HF At least one-half have heart failure with reduced ejection fraction (HF- REF) The most common
More informationFeasibility of Leadless Cardiac Pacing Using Injectable. Magnetic Microparticles
Supplementary Information for Feasibility of Leadless Cardiac Pacing Using Injectable Magnetic Microparticles Menahem Y. Rotenberg, Hovav Gabay, Yoram Etzion and Smadar Cohen. Correspondence to: scohen@bgu.ac.il,
More informationPyruvate + NADH + H + ==== Lactate + NAD +
1 UNIVERSITY OF PAPUA NEW GUINEA SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY PBL SEMINAR ANAEROBIC METABOLISM - An Overview
More informationCONSEQUENCES OF MYOCARDIAL ISCHEMIA
Página 1 de 8 CONSEQUENCES OF MYOCARDIAL ISCHEMIA Part of "46 - Coronary Blood Flow and Myocardial Ischemia" Metabolic Consequences During ischemia, several metabolic changes occur. Adenosine triphosphate
More informationPathophysiology of Coronary Microvascular Dysfunction
Pathophysiology of Coronary Microvascular Dysfunction Cheol Woong Yu, MD, PhD Cardiology Department Division of Internal Medicine Korea University Anam Hospital. Etiologies of Chest Pain without obstructive
More information6. Lochner, A., Tromp, E., Mouton, R. Signal transduction in myocardial ischaemia and reperfusion. Mol Cell Biochem., 160/161: , 1996.
PUBLICATIONS IN PEER-REVIEWED JOURNALS: 1. Moolman, J.A., Genade, S., Tromp, E., Lochner, A. Ischaemic preconditioning: interaction with antiadrenergic interventions. J Mol Cell Cardiol 27(6): A161, June
More informationAmeliorating Reperfusion Injury During Resuscitation from Cardiac Arrest
Ameliorating Reperfusion Injury During Resuscitation from Cardiac Arrest Scott T. Youngquist, MD, MSc Associate Professor, Emergency Medicine University of Utah School of Medicine Medical Director, Salt
More informationIschaemic heart disease. IInd Chair and Clinic of Cardiology
Ischaemic heart disease IInd Chair and Clinic of Cardiology Definition Syndrome due to chronic insufficient oxygen supply to myocardial cells Nomenclature: ischaemic heart disease (IHD), coronary artery
More informationEssam Mahfouz, MD. Professor of Cardiology, Mansoura University
By Essam Mahfouz, MD. Professor of Cardiology, Mansoura University Agenda Definitions Classifications Epidemiology Risk stratification What is new? What is MI? Myocardial infarction is the death of part
More informationEFFECT OF INFARCT SIZE LIMITATION BY PROPRANOLOL ON VENTRICULAR ARRHYTHMIAS AFTER MYOCARDIAL INFARCTION
EFFECT OF INFARCT SIZE LIMITATION BY PROPRANOLOL ON VENTRICULAR ARRHYTHMIAS AFTER MYOCARDIAL INFARCTION James R. Stewart,* John K. Gibson,? and Benedict R. Lucchesi t Departments of Internal Medicine *
More informationAngiotensin-converting enzyme inhibitors potentiate subthreshold preconditioning through NO and mitok ATP. channel
Acta Physiologica Sinica, August 25, 2005, 57 (4): 453-460 http://www.actaps.com.cn 453 ATP 1 1 1 2 2 2,* 1 313000 2 310006 Langendorff ( ) ( ) (angiotensin-converting enzyme inhibitors, ACEI) (nitric
More informationCardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
More informationTopic Page: congestive heart failure
Topic Page: congestive heart failure Definition: congestive heart f ailure from Merriam-Webster's Collegiate(R) Dictionary (1930) : heart failure in which the heart is unable to maintain an adequate circulation
More informationReperfusion Effects After Cardiac Ischemia
Reperfusion Effects After Cardiac Ischemia Dave Milzman, MD, FACEP Professor and Assistant Dean for Clinical Research Georgetown University School of Medicine Research Director, Depts of Trauma and Emerg
More informationStable Ischemic Heart Disease. Ivan Anderson, MD RIHVH Cardiology
Stable Ischemic Heart Disease Ivan Anderson, MD RIHVH Cardiology Outline Review of the vascular biology of atherosclerosis Why not just cath everyone with angina? Medical management of ischemic cardiomyopathy
More informationAge-related changes in cardiovascular system. Dr. Rehab Gwada
Age-related changes in cardiovascular system Dr. Rehab Gwada Objectives explain the main structural and functional changes in cardiovascular system associated with normal aging Introduction aging results
More informationHigh Risk PCI for Heart Failure
High Risk PCI for Heart Failure Ray Matthews MD Professor of Clinical Medicine Chief, Division of Cardiovascular Medicine University of Southern California Los Angeles, California Disclosures Abiomed Research
More informationCardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.
Complete the following. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate. 2. drugs affect the force of contraction and can be either positive or negative. 3.
More informationElectrophysiological effects of haloperidol on isolated rabbit Purkinje fibers and guinea pigs papillary muscles under normal and simulated ischemia
Acta Pharmacol Sin 2007 Aug; 28 (8): 1155 1160 Short communication Electrophysiological effects of haloperidol on isolated rabbit Purkinje fibers and guinea pigs papillary muscles under normal and simulated
More informationSean Davidson. The Hatter Cardiovascular Institute University College London, UK
Key pathways to ischemia-reperfusion injury Sean Davidson The Hatter Cardiovascular Institute University College London, UK Outline What is ischaemia-reperfusion injury? What causes ischaemia-reperfusion
More informationSevere left ventricular dysfunction and valvular heart disease: should we operate?
Severe left ventricular dysfunction and valvular heart disease: should we operate? Laurie SOULAT DUFOUR Hôpital Saint Antoine Service de cardiologie Pr A. COHEN JESFC 16 janvier 2016 Disclosure : No conflict
More informationDiazoxide Provides Protection to Human Myocardium In Vitro That Is Concentration Dependent
Diazoxide Provides Protection to Human Myocardium In Vitro That Is Concentration Dependent Marek A. Deja, MD, Krzysztof S. Golba, MD, PhD, Maciej Kolowca, MD, Kazimierz Widenka, MD, Jolanta Biernat, MD,
More informationSUPPLEMENTAL MATERIAL. Supplementary Methods
SUPPLEMENTAL MATERIAL Supplementary Methods Culture of cardiomyocytes, fibroblasts and cardiac microvascular endothelial cells The isolation and culturing of neonatal rat ventricular cardiomyocytes was
More informationA DAYS CARDIOVASCULAR UNIT GUIDE DUE WEDNESDAY 4/12
A DAYS CARDIOVASCULAR UNIT GUIDE DUE WEDNESDAY 4/12 MONDAY TUESDAY WEDNESDAY THURSDAY FRIDAY 3/20 - B 3/21 - A 3/22 - B 3/23 - A 3/24 - B 3/27 - A Dissection Ethics Debate 3/28 - B 3/29 - A Intro to Cardiovascular
More informationThe Journal of Thoracic and Cardiovascular Surgery
Accepted Manuscript Nitric Oxide: Might make it Better? J. Hunter Mehaffey, MD, MSc, Robert B. Hawkins, MD, MSc PII: S0022-5223(18)32342-0 DOI: 10.1016/j.jtcvs.2018.08.070 Reference: YMTC 13398 To appear
More informationEnhanced CABG is in Your Hands
An Intraoperative Treatment for Preserving Vascular Grafts Enhanced CABG is in Your Hands Intraoperative Graft Damage is the Principal Cause of Vein Graft Failure (VGF) The durability and patency of vein
More informationImportance of the third arterial graft in multiple arterial grafting strategies
Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular
More informationCardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology
Cardiovascular Disorders Bio 375 Pathophysiology Heart Disorders Heart disease is ranked as a major cause of death in the U.S. Common heart diseases include: Congenital heart defects Hypertensive heart
More informationPreconditioning, postconditioning and their application to clinical cardiology
Cardiovascular Research 70 (2006) 297 307 Review Preconditioning, postconditioning and their application to clinical cardiology Robert A. Kloner a, *, Shereif H. Rezkalla b a Heart Institute, Good Samaritan
More informationOriginal Article. Introduction
Original Article The Effects of Na Movement on Surgical Myocardial Protection: The Role of the Na + -H + Exchange System and Na-Channel in the Development of Ischemia and Reperfusion Injury Ke-Xiang Liu,
More informationVentricular Arrhythmias in Acute MI Patients Undergoing Primary PCI
Ventricular Arrhythmias in Acute MI Patients Undergoing Primary PCI Bulent Gorenek MD FACC FESC Eskişehir Osmangazi University Cardiology Department Eskisehir-Turkey I do not have any potential conflict
More informationOUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION
OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION FEROZ MEMON*, LIAQUAT CHEEMA**, NAND LAL RATHI***, RAJ KUMAR***, NAZIR AHMED MEMON**** OBJECTIVE: To compare morbidity,
More informationFrom left bundle branch block to cardiac failure
OF JOURNAL HYPERTENSION JH R RESEARCH Journal of HYPERTENSION RESEARCH www.hypertens.org/jhr Original Article J Hypertens Res (2017) 3(3):90 97 From left bundle branch block to cardiac failure Cătălina
More informationPathophysiology of ischemia-reperfusion injury (and how to protect against it )
Pathophysiology of ischemia-reperfusion injury (and how to protect against it ) Dr Derek J Hausenloy Reader in Cardiovascular Medicine BHF Senior Clinical Research Fellow Honorary Consultant Cardiologist
More informationJournal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL
More informationSupplementary Online Content
Supplementary Online Content Inohara T, Manandhar P, Kosinski A, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter
More informationHEART CONDITIONS IN SPORT
HEART CONDITIONS IN SPORT Dr. Anita Green CHD Risk Factors Smoking Hyperlipidaemia Hypertension Obesity Physical Inactivity Diabetes Risks are cumulative (multiplicative) Lifestyles predispose to RF One
More informationDrug Treatment of Ischemic Heart Disease
Drug Treatment of Ischemic Heart Disease Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan November, 2014 Categories of Ischemic Heart Disease Fixed "Stable, Effort Angina Variant
More informationIn the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension
In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial
More informationClinical benefits of trimetazidine in diabetic patients with coronary artery disease
Clinical benefits of trimetazidine in diabetic patients with coronary artery disease Department of Cardiology, Ain Shams University, Cairo, Egypt Correspondence:, Department of Cardiology, Ain Shams University,
More informationA Comparative Study on the Effect of Ranolazine and Ivabradine on High Sensitivity C - reactive protein In Cardiac Patients
Human Journals Mini Review March 2017 Vol.:8, Issue: 4 All rights are reserved by Prof. Dr. Mathew George et al. A Comparative Study on the Effect of Ranolazine and Ivabradine on High Sensitivity C - reactive
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationSurgery and device intervention for the elderly with heart failure: assessing the need. Devices and Technology for heart failure in 2011
Surgery and device intervention for the elderly with heart failure: assessing the need Devices and Technology for heart failure in 2011 Assessing cardiovascular function / prognosis (in the elderly): composite
More informationin Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D.
Factors Relating to Late Sudden Death in Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D. ABSTRACT The preoperative
More informationCORONARY ARTERY DISEASES
CORONARY ARTERY DISEASES It has been estimated that over one third of the population eventually will die of CAD, and 20% will develop symptoms when younger than age 60 years. ANATOMY OF THE CORONARY ARTERIES
More informationDrug Treatment of Ischemic Heart Disease
Drug Treatment of Ischemic Heart Disease Munir Gharaibeh, MD, PhD, MHPE School of Medicine, The University of Jordan November, 2017 Categories of Ischemic Heart Disease Fixed "Stable, Effort Angina Variant
More informationI have no financial disclosures
Manpreet Singh MD I have no financial disclosures Exercise Treadmill Bicycle Functional capacity assessment Well validated prognostic value Ischemic assessment ECG changes ST segments Arrhythmias Hemodynamic
More informationCorrelations among copeptin, ischemia-modified albumin, and the extent of myocardial injury in patients with acute carbon monoxide poisoning
Correlations among copeptin, ischemia-modified albumin, and the extent of myocardial injury in patients with acute carbon monoxide poisoning J. Li, J.S. Wang, Z.X. Xie, W.Z. Wang, L. Wang, G.Y. Ma, Y.Q.
More information